Your browser doesn't support javascript.
loading
Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study.
Lamarca, Angela; Ronot, Maxime; Moalla, Salma; Crona, Joakim; Opalinska, Marta; Lopez Lopez, Carlos; Pezzutti, Daniela; Najran, Pavan; Carvhalo, Luciana; Bezerra, Regis Otaviano Franca; Borg, Philip; Vietti Violi, Naik; Vidal Trueba, Hector; de Mestier, Louis; Scaefer, Niklaus; Baudin, Eric; Sundin, Anders; Costa, Frederico; Pavel, Marianne; Dromain, Clarisse.
Afiliación
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. angela.lamarca@christie.nhs.uk.
  • Ronot M; Department of Radiology, Beaujon University Hospital, Clichy, France.
  • Moalla S; Department of Radiology, Institute Gustave Roussy, Paris, France.
  • Crona J; Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden.
  • Opalinska M; Nuclear Medicine Unit, Department of Endocrinology, University Hospital, Krakow, Poland.
  • Lopez Lopez C; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Pezzutti D; Department of Radiology, Israelita Albert Einstein Hospital, São Paulo, Brazil.
  • Najran P; Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Carvhalo L; Department of Medical Oncology, Sirio-Libanes Hospital, São Paulo, Brazil.
  • Bezerra ROF; Department of Radiology, Sirio-Libanes Hospital, São Paulo, Brazil and São Paulo Cancer Institute Octavio Frias de Oliveira (ICESP), São Paulo, Brazil.
  • Borg P; Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Vietti Violi N; Department of Radiology, CHUV University Hospital, Lausanne, Switzerland.
  • Vidal Trueba H; Department of Radiology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • de Mestier L; Department of Gastroenterology, Beujon University Hospital, Clichy, France.
  • Scaefer N; Department of Medical Oncology, CHUV University Hospital, Lausanne, Switzerland.
  • Baudin E; Department of Nuclear Medicine, Institute Gustave Roussy, Paris, France.
  • Sundin A; Department of Radiology, Institution of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
  • Costa F; Department of Medical Oncology; Sirio-Libanes Hospital, São Paulo, Brazil.
  • Pavel M; Department of Endocrinology, Universitatsklinikum Erlangen, Erlangen, Germany.
  • Dromain C; Department of Radiology, CHUV University Hospital, Lausanne, Switzerland.
Clin Cancer Res ; 25(22): 6692-6699, 2019 11 15.
Article en En | MEDLINE | ID: mdl-31375514
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiografía / Biomarcadores / Tumores Neuroendocrinos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radiografía / Biomarcadores / Tumores Neuroendocrinos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos